Tranche Update on Huons Global Co., Ltd.'s Equity Buyback Plan announced on August 14, 2020.
February 23, 2021 at 02:51 am
Share
From January 1, 2021 to February 18, 2021, the company has repurchased 61,885 shares, representing 0.52% for KRW 1,759.8 million. With this, the company has completed the repurchase of 133,523 shares, representing 1.12% for KRW 3,990.62 million under the buyback announced on August 14, 2020.
Huons Global Co., Ltd., formerly, Huons Co., Ltd. is Kore-based entity principally engaged in the manufacture and distribution of pharmaceutical products. Along with its subsidiaries, the Company operates its business through two segments: pharmaceutical segment and glass container segment. The pharmaceutical segment produces pharmaceutical products including parenteral injections such as lidocaines, merit C injections; tablets such as phentermines, diet pills and others; capsules such as Daisen and Fuxetine and other ethical and over-the-counter drugs. The glass container segment produces ampoules, vials, cartridges and caps for used of medicals, foods and cosmetics. The Company also manufactures medical devices such as kits, derma injectors and other injector.
HUONS GLOBAL CO., LTD. 
